Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000919574-25-005054·BIOLIFE SOLUTIONS INC
Schedule 13D ownership disclosure
BioLife Solutions Inc
Common Stock, par value $0.001 per share · CUSIP: 09062W204
Event date: 2025-08-15
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Casdin Capital, LLCReported CIK 0001534261
Shares: 6,707,165.00 · Class: 14.0%
- Casdin Partners Master Fund, L.P.Reported CIK 0001534265
Shares: 6,707,165.00 · Class: 14.0%
- Casdin Partners GP, LLCReported CIK 0001534260
Shares: 6,707,165.00 · Class: 14.0%
- Eli CasdinReported CIK 0001534264
Shares: 6,707,165.00 · Class: 14.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-005054
- Form type
- SCHEDULE 13D/A
- Filer
- BIOLIFE SOLUTIONS INC
- CIK
- CIK 834365
- Filed
- Aug 21, 2025
- Reporting period
- Aug 15, 2025
- Description
- Schedule 13D beneficial ownership